MiNK Therapeutics (INKT) Stock Chart & Stock Price History $8.23 +0.31 (+3.88%) As of 02:26 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends MiNK Therapeutics Stock Price Performance 5 Day Performance-6.71%1 Month Performance-17.59%3 Month Performance+51.15%6 Month Performance+5.07%Year-To-Date Performance+13.65%1 Year Performance-11.61% Receive INKT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MiNK Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address INKT Stock Chart for Thursday, March, 20, 2025 INKT Chart by TradingViewRemove Ads MiNK Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/19/2025$8.24$7.92-3.88%$8.65$7.807,877 shs$31.39 million03/18/2025$8.52$8.24-3.29%$9.22$7.7032,258 shs$32.66 million03/17/2025$8.49$8.52+0.35%$9.71$8.5215,686 shs$33.77 million03/14/2025$7.98$8.49+6.39%$8.49$8.182,478 shs$33.65 million03/13/2025$7.98$7.98$8.50$7.814,816 shs$31.63 million03/12/2025$7.81$7.98+2.18%$8.43$7.825,377 shs$31.63 million03/11/2025$7.66$7.81+1.96%$8.39$7.547,107 shs$30.95 million03/10/2025$8.20$7.66-6.59%$8.43$7.5411,082 shs$30.36 million03/07/2025$8.16$8.20+0.49%$8.88$8.1112,093 shs$32.50 million03/06/2025$8.15$8.16+0.12%$8.80$7.9012,356 shs$32.34 million Get the Latest News and Ratings for INKT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MiNK Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 03/05/2025$8.10$8.15+0.62%$8.62$8.093,013 shs$32.30 million03/04/2025$8.79$8.10-7.85%$8.52$7.7914,862 shs$32.10 million03/03/2025$8.95$8.79-1.79%$8.80$8.3911,609 shs$34.84 million02/28/2025$9.26$8.95-3.33%$9.05$7.9011,343 shs$35.47 million02/27/2025$9.37$9.26-1.20%$9.41$8.874,812 shs$36.69 million02/26/2025$9.73$9.37-3.70%$9.54$9.206,456 shs$37.13 million02/25/2025$10.65$9.73-8.64%$10.74$9.0924,580 shs$38.53 million02/24/2025$10.18$10.65+4.58%$12.00$9.9920,458 shs$42.17 million02/21/2025$9.61$10.18+5.97%$10.38$9.916,320 shs$40.33 million02/20/2025$9.49$9.61+1.26%$10.00$8.9713,173 shs$38.06 million02/19/2025$9.95$9.49-4.62%$9.82$9.404,468 shs$37.58 million Related Companies Coherus BioSciences Stock Chart Adaptimmune Therapeutics Stock Chart Sutro Biopharma Stock Chart Invivyd Stock Chart Coya Therapeutics Stock Chart Kyverna Therapeutics Stock Chart Sagimet Biosciences Stock Chart Instil Bio Stock Chart Procaps Group Stock Chart Fate Therapeutics Stock Chart Receive INKT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MiNK Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:INKT) was last updated on 3/20/2025 by MarketBeat.com Staff From Our PartnersDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredMusk’s real agenda in D.C. Companies connected to Elon’s new map of America are making major climbs in price. And on May 30, the next wav...Porter & Company | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | Sponsored2025 Market CrashThe same data indicates we WILL likely see a market crash during President Trump's second year in office - 202...Chaikin Analytics | Sponsored92% win rate – even whe the market crashesMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredForget Bitcoin: This Under-the-Radar Stock Is the Real WinnerThe financial world just changed overnight. Trump just shocked the markets by announcing that the U.S. stra...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MiNK Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MiNK Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
